Inventor · disambiguated record
Zhenwei Cai
Also filed as: CAI ZHENWEI
21 granted patents·12 pending applications·112 citations·filing 2013–2024
94Inventor score
Files withAGIOS PHARMACEUTICALS INC21SERVIER PHARMACEUTICALS LLC4ZAFGEN INC4ANTENGENE DISCOVERY LTD1LEMIEUX RENE M1
Top patents by PatentIndex Score
33 records- 0197US11040036B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 22, 2021·7 cites·26 claims
- 0297US9850277B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 26, 2017·22 cites·16 claims
- 0397US9579324B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2014·Granted Feb 28, 2017·22 cites·6 claims
- 0496US9474779B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Oct 25, 2016·36 cites·18 claims
- 0595US10172864B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 8, 2019·8 cites·21 claims
- 0690US10028961B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jul 24, 2018·4 cites·9 claims
- 0789US11464775B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Oct 11, 2022·3 cites·21 claims
- 0889US2025144093A1Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0988US11364240B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 21, 2022·4 cites·27 claims
- 1087US11844758B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2021·Granted Dec 19, 2023·1 cites·20 claims
- 1187US10717764B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Jul 21, 2020·1 cites·2 claims
- 1285US2024059733A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 1384US12133853B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Nov 5, 2024·0 cites·25 claims
- 1483US10640534B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 5, 2020·2 cites·6 claims
- 1581US11957680B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Apr 16, 2024·0 cites·14 claims
- 1679US11872225B2Pyruvate kinase modulators and use thereofAGIOS PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·0 cites·22 claims
- 1779US11590132B2Pyruvate kinase activators for use in treating blood disordersAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Feb 28, 2023·1 cites·24 claims
- 1877US12433895B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2023·Granted Oct 7, 2025·0 cites·20 claims
- 1974US11667673B2Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 2073US9944613B2Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2017·Granted Apr 17, 2018·1 cites·14 claims
- 2172US11021515B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jun 1, 2021·0 cites·1 claims
- 2271US10689414B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Jun 23, 2020·0 cites·1 claims
- 2367US10946023B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Mar 16, 2021·0 cites·35 claims
- 2464US2015031627A1Therapeutically active compounds and their methods of useLEMIEUX RENE M·Filed 2014·Application pending·0 cites
- 2560US2017057994A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2659US2016130298A1Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2758US2019092781A1Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 2856US2019023716A1Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2018·Application pending·0 cites
- 2952US2018237449A1Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using sameZAFGEN INC·Filed 2016·Application pending·0 cites
- 3049US2015087600A1Therapeutically active compounds and their methods of usePOPOVICI-MULLER JANETA·Filed 2013·Application pending·0 cites
- 3148US2025230140A1Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonistsVIVA STAR BIOSCIENCES SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3246US2023295166A1Atr inhibitors and uses thereofANTENGENE DISCOVERY LTD·Filed 2021·Application pending·0 cites
- 3346US2016304556A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhenwei Cai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →